Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors

Ana M. Metelo, Reuben Benjamin, Le Anh Luong et al.|Cancer Research Communications|2022

Cited by 39